Doctors and experts are split over calls to expand the eligibility for leading Covid antiviral drugs Paxlovid and Lagevrio, with some saying access should be widened while others warn the medication isn’t right for everyone.
The federal health minister, Mark Butler, is encouraging doctors and patients to consider the drugs, which can be effective at lessening the virus’s symptoms if taken soon after contracting Covid.
